CoChat

Ascites-derived IL-6 and IL-10 synergistically expand CD14+HLA-DR-/low myeloid-derived suppressor cells in ovarian cancer patients

Open access
Wu, Liangliang, Deng, Zhaoyang, Peng, Yaojun, Han, Lu, Liu, Jing, Wang, Linxiong, Li, Bohua, Zhao, Jian, Jiao, Shunchang, Wei, Huafeng · 2017 · Oncotarget
Cited by 114

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Abstract

// Liangliang Wu 1, * , Zhaoyang Deng 2, * , Yaojun Peng 1 , Lu Han 3 , Jing Liu 1 , Linxiong Wang 1 , Bohua Li 4 , Jian Zhao 4 , Shunchang Jiao 1, 3 and Huafeng Wei 1 1 Key Lab of Cancer Center, General Hospital of Chinese PLA & Beijing Key Laboratory of Cell Engineering & Antibody, Beijing, China 2 Surgical Division, General Hospital of Chinese PLA, Beijing, China 3 Department of Internal Oncology, General Hospital of Chinese PLA, Beijing, China 4 Shanghai Key Laboratory for Molecular Imaging, Shanghai University of Medicine & Health Sciences, Shanghai, China * These authors have contributed equally to the work Correspondence to: Huafeng Wei, email: foxp3_smmu@163.com Shunchang Jiao, email: jiaosc@me.com Keywords: MDSC, ovarian cancer, IL-6, IL-10, STAT3 Received: March 13, 2017 Accepted: June 27, 2017 Published: August 10, 2017 ABSTRACT Myeloid-derived suppressor cells (MDSC) play a key immunosuppressive role in various types of cancer, including ovarian cancer (OC). In this study, we characterized CD14 + HLA-DR −/lo MDSC with a typical monocytic phenotype (M-MDSC) in the peripheral blood (PB) and ascites from OC patients. Compared to healthy donors, OC patients had a significantly increased abundance of M-MDSC in both PB and ascites; importantly, their abundance in both compartments was inversely associated with the prognosis where OC patients with higher level of M-MDSC having a shorter relapse-free survival. Intriguingly, we demonstrated that M-MDSC could be readily induced by ascitic fluids (AF) from OC patients, which was predominantly dependent on IL-6, IL-10 and STAT3 activation as neutralization of IL-6 and/or IL-10 or inhibition of STAT3 abrogated MDSC’s expansion while recombinant IL-6 and IL-10 recapitulated the expansive effect of AF; furthermore, predominantly elevated levels of IL-6 and IL-10 has been noted in the AF which was positively correlated with the abundance of M-MDSC as well as poor prognosis of OC patients. As expected, we observed that AF-driven STAT3 activation upregulated the expression of arginase (ARG1) and inducible nitric oxide synthase (iNOS) in induced M-MDSC through which these MDSC executed the immunosuppressive activity. Taken together, these results demonstrate that abundant M-MDSC are present in both periphery and ascites of OC patients whose accumulation and suppressive activity is critically attributable to ascites-derived IL-6 and IL-10 and their downstream STAT3 signal, thus providing a potentially novel therapeutic option by locally targeting MDSC to improve antitumor efficacy.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.18632/oncotarget.20164

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 114

Metadata

Authors
Wu, L., Deng, Z., Peng, Y., Han, L., Liu, J., Wang, L., Li, B., Zhao, J., Jiao, S., & Wei, H.
Venue
Oncotarget
Published
2017-08-10
Volume
8
Issue
44
Pages
76843-76856
ISSN
1949-2553 (ISSN-L)
OpenAlex
W2742440809
Cited by
114
References
5
FWCI
4.08
Type
journal article
Language
en
Open access
diamond

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.